Offer - Urjas Oil for just ₹ 1 X
Zedocef CV 200 Tablet is a commercial drug that is prescribed in the form of Tablet. The alternative uses of Zedocef CV 200 Tablet have also been explained below.
The correct dosage of Zedocef CV 200 Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Zedocef CV 200 Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Zedocef CV 200 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Zedocef CV 200 Tablet is Mild for pregnant women and Moderate for women who are breastfeeding. Further, the section on Zedocef CV 200 Tablet related warnings talks about Zedocef CV 200 Tablet's effects on the liver, heart and kidney.
Zedocef CV 200 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Zedocef CV 200 Tablet in conditions like Jaundice. The section on Zedocef CV 200 Tablet contraindications lists all such conditions.
Additionally, Zedocef CV 200 Tablet may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Zedocef CV 200 Tablet is considered safe while driving, and is addictive.
Zedocef CV 200 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Zedocef CV 200 Tablet safe for pregnant women?
Pregnant women can consume [medicine]. Though Zedocef CV has mild side effects when taken during pregnany
Is the use of Zedocef CV 200 Tablet safe during breastfeeding?
Zedocef CV can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Zedocef CV 200 Tablet on the Kidneys?
There can be some harmful effects on your kidneys after taking Zedocef CV. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Zedocef CV 200 Tablet on the Liver?
Zedocef CV can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Zedocef CV 200 Tablet on the Heart?
Side effects of Zedocef CV rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Zedocef CV 200 Tablet unless your doctor advises you to do so -
Is this Zedocef CV 200 Tablet habit forming or addictive?
No, there is no any evidence that Zedocef CV 200 Tablet is addictive.
Interaction between Food and Zedocef CV 200 Tablet
Taking Zedocef CV 200 Tablet with food is safe.
Interaction between Alcohol and Zedocef CV 200 Tablet
Information about the interaction of Zedocef CV 200 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311